Article Information
History
- August 4, 2021.
Article Versions
- Version 1 (March 30, 2020 - 10:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lijiao Zeng†,1,
- Jialu Li†,*,7,
- Mingfeng Liao†,4,
- Rui Hua†,7,
- Pilai Huang2,
- Mingxia Zhang4,
- Youlong Zhang7,
- Qinlang Shi2,
- Zhaohua Xia2,
- Xinzhong Ning2,
- Dandan Liu2,
- Jiu Mo7,
- Ziyuan Zhou2,
- Zigang Li5,
- Yu Fu2,
- Yuhui Liao6,
- Jing Yuan1,
- Lifei Wang3,
- Qing He4,
- Lei Liu*,4 and
- Kun Qiao*,2
- 1Department of Infectious Diseases of National Clinical Research Center for Infectious Disease, China
- 2Department of Thoracic Surgery of National Clinical Research Center for Infectious Disease, China
- 3Department of Radiology of National Clinical Research Center for Infectious Disease, China
- 4The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen Third People’s Hospital, China
- 5Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, and State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, China
- 6Molecular Diagnosis and Treatment Center for Infectious Diseases, Dermatology Hospital, Southern Medical University, China
- 7Department of Biostatistics, HuaJia Biomedical Intelligence, Shenzhen, China
- ↵*Correspondence should be addressed to Dr. Qiao, szqiaokun{at}163.com; or to Dr. Li, Jialu.li{at}huajiabio.com; or to Dr. Liu, liulei1961{at}hotmail.com
↵† These authors contributed equally
Posted August 04, 2021.
Risk assessment of progression to severe conditions for patients with COVID-19 pneumonia: a single-center retrospective study
